CNS & Neurological Disorders - Drug Targets
Title:Commentary: Toward a Personalized Medicine in Wake-Up Stroke?
Volume: 16 Issue: 10
Author(s): Burak Yulug*, Lutfu Hanoglu and Ertugrul Kilic
Affiliation:
- Regenerative and Restorative Medical Research Center (REMER), University of Istanbul-Medipol, Istanbul,Turkey
Export Options
About this article
Cite this article as:
Yulug Burak*, Hanoglu Lutfu and Kilic Ertugrul , Commentary: Toward a Personalized Medicine in Wake-Up Stroke?, CNS & Neurological Disorders - Drug Targets 2017; 16 (10) . https://dx.doi.org/10.2174/1871527316666170727124327
DOI https://dx.doi.org/10.2174/1871527316666170727124327 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
43
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Vascular Endothelial Growth Factor in Neurogenesis in Adult Brain
Mini-Reviews in Medicinal Chemistry Blood Pressure as a Therapeutic Target in Stroke
Current Topics in Medicinal Chemistry Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry Turnover Studies on Cardiac Natriuretic Peptides: Methodological,Pathophysiological and Therapeutical Considerations.
Current Drug Metabolism Computational Studies on Translocator Protein (TSPO) and its Ligands
Current Topics in Medicinal Chemistry Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Nanog Overexpression Increases Neural Marker Expression in Adipose Derived Stem Cells
Recent Patents on Regenerative Medicine Editorial: Exciting Progresses in Stem Cell and Neural Stem Cell Research
Current Molecular Medicine Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Neonatal and Long-Term Consequences of Fetal Growth Restriction
Current Pediatric Reviews Role of Nitric Oxide Signaling Pathways in Brain Injuries
Current Chemical Biology Effect of Particle Formulation on Dry Powder Inhalation Efficiency
Current Pharmaceutical Design Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
Current Neuropharmacology Post-cardiac Arrest Syndrome in Children
Current Pediatric Reviews Stable Gastric Pentadecapeptide BPC 157-NO-system Relation
Current Pharmaceutical Design Repulsive Apoptosis During Exposure of Mesencephalic Neural Stem Cells to Silver Nanoparticles in a Neurosphere Assay In Vitro
Current Drug Discovery Technologies Immune Endocrinological Evaluation in Patients with Severe Vascular Acquired Brain Injuries: Therapeutical Approaches
Endocrine, Metabolic & Immune Disorders - Drug Targets